248 related articles for article (PubMed ID: 22876922)
1. Adiponectin in diabetes mellitus.
Xita N; Tsatsoulis A
Curr Med Chem; 2012; 19(32):5451-8. PubMed ID: 22876922
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin and adiponectin receptors in obesity-linked insulin resistance.
Kadowaki T; Yamauchi T; Kubota N; Hara K; Ueki K
Novartis Found Symp; 2007; 286():164-76; discussion 176-82, 200-3. PubMed ID: 18269182
[TBL] [Abstract][Full Text] [Related]
4. The Role of Ceramides in Diabetes and Cardiovascular Disease Regulation of Ceramides by Adipokines.
Field BC; Gordillo R; Scherer PE
Front Endocrinol (Lausanne); 2020; 11():569250. PubMed ID: 33133017
[TBL] [Abstract][Full Text] [Related]
5. Adiponectin: A potential therapeutic target for metabolic syndrome.
Ghadge AA; Khaire AA; Kuvalekar AA
Cytokine Growth Factor Rev; 2018 Feb; 39():151-158. PubMed ID: 29395659
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction.
Achari AE; Jain SK
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635626
[TBL] [Abstract][Full Text] [Related]
7. Hypoadiponectinemia as a marker of adipocyte dysfunction--part II: the functional significance of low adiponectin secretion.
Stern N; Osher E; Greenman Y
J Cardiometab Syndr; 2007; 2(4):288-94. PubMed ID: 18059213
[TBL] [Abstract][Full Text] [Related]
8. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
Matsuda M; Shimomura I
Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
[TBL] [Abstract][Full Text] [Related]
9. Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country.
Barbosa-Cortés L; López-Alarcón M; Mejía-Aranguré JM; Klünder-Klünder M; Del Carmen Rodríguez-Zepeda M; Rivera-Márquez H; de la Vega-Martínez A; Martin-Trejo J; Shum-Luis J; Solis-Labastida K; López-Aguilar E; Matute-González G; Bernaldez-Rios R
BMC Cancer; 2017 Feb; 17(1):125. PubMed ID: 28193268
[TBL] [Abstract][Full Text] [Related]
10. [Adiponectin: a new link between obesity, insulin resistance and cardiovascular disease].
Palomer X; Pérez A; Blanco-Vaca F
Med Clin (Barc); 2005 Mar; 124(10):388-95. PubMed ID: 15766512
[TBL] [Abstract][Full Text] [Related]
11. [Adiponectin as an adipose tissue hormone and its role in the metabolic syndrome and cardiovascular disease].
Pańkowska E; Szalecki M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):187-90. PubMed ID: 16232373
[TBL] [Abstract][Full Text] [Related]
12. Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.
Yamauchi T; Kadowaki T
Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S13-8. PubMed ID: 19136982
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin and its association with insulin resistance and type 2 diabetes.
Sheng T; Yang K
J Genet Genomics; 2008 Jun; 35(6):321-6. PubMed ID: 18571119
[TBL] [Abstract][Full Text] [Related]
14. The Role of Adiponectin in Maintaining Metabolic Homeostasis.
Adiyaman SC; Ozer M; Saydam BO; Akinci B
Curr Diabetes Rev; 2020; 16(2):95-103. PubMed ID: 31267874
[TBL] [Abstract][Full Text] [Related]
15. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
Matsuda M; Shimomura I
Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
[TBL] [Abstract][Full Text] [Related]
16. Fetuin-A is also an adipokine.
Jialal I; Pahwa R
Lipids Health Dis; 2019 Mar; 18(1):73. PubMed ID: 30917813
[TBL] [Abstract][Full Text] [Related]
17. Adiponectin and its role in the obesity-induced insulin resistance and related complications.
Haluzík M; Parízková J; Haluzík MM
Physiol Res; 2004; 53(2):123-9. PubMed ID: 15046547
[TBL] [Abstract][Full Text] [Related]
18. Modulation of adiponectin as a potential therapeutic strategy.
Lim S; Quon MJ; Koh KK
Atherosclerosis; 2014 Apr; 233(2):721-728. PubMed ID: 24603219
[TBL] [Abstract][Full Text] [Related]
19. Adiponectin: regulation of its production and its role in human diseases.
Shehzad A; Iqbal W; Shehzad O; Lee YS
Hormones (Athens); 2012; 11(1):8-20. PubMed ID: 22450341
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin in health and disease.
Oh DK; Ciaraldi T; Henry RR
Diabetes Obes Metab; 2007 May; 9(3):282-9. PubMed ID: 17391153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
